Corvus Pharmaceuticals, Inc. Increase (Decrease) in Other Noncurrent Assets
Corvus Pharmaceuticals, Inc. (CRVS) reported Increase (Decrease) in Other Noncurrent Assets of -$180.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentAssets · last filed 2026-08-06
- Corvus Pharmaceuticals, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2026-06-30 was -$92.00K.
- Corvus Pharmaceuticals, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2026-03-31 was -$88.00K.
- Corvus Pharmaceuticals, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2025-12-31 was -$88.00K, a 109.85% decline year-over-year.
- Corvus Pharmaceuticals, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2025-09-30 was -$85.00K.
- Corvus Pharmaceuticals, Inc. increase (decrease) in other noncurrent assets for fiscal 2025 was -$338.00K, a 1307.14% decline from fiscal 2024.
- Corvus Pharmaceuticals, Inc. increase (decrease) in other noncurrent assets for fiscal 2024 was $28.00K.
- Corvus Pharmaceuticals, Inc. increase (decrease) in other noncurrent assets for fiscal 2023 was -$1.07M.
- Corvus Pharmaceuticals, Inc. increase (decrease) in other noncurrent assets for fiscal 2022 was -$973.00K.
| Period end | Increase (Decrease) in Other Noncurrent Assets 3 month | Increase (Decrease) in Other Noncurrent Assets 3 month as first filed | Increase (Decrease) in Other Noncurrent Assets 6 month | Increase (Decrease) in Other Noncurrent Assets 9 month | Increase (Decrease) in Other Noncurrent Assets 12 month | Increase (Decrease) in Other Noncurrent Assets 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$92.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$180.00K 10-Q · filed 2026-08-06 | -$268.00K derived: sum of 3 quarters · filed 2026-08-06 | -$353.00K derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2026-03-31 | -$88.00K 10-Q · filed 2026-05-07 | -$176.00K derived: sum of 2 quarters · filed 2026-05-07 | -$261.00K derived: sum of 3 quarters · filed 2026-05-07 | -$344.00K derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-12-31 | -$88.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$173.00K derived: sum of 2 quarters · filed 2026-03-12 | -$256.00K derived: sum of 3 quarters · filed 2026-08-06 | -$338.00K 10-K · filed 2026-03-12 | ||
| 2025-09-30 | -$85.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$168.00K derived: sum of 2 quarters · filed 2026-08-06 | -$250.00K 10-Q · filed 2025-11-04 | $643.00K derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-06-30 | -$83.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$165.00K 10-Q · filed 2026-08-06 | $728.00K derived: sum of 3 quarters · filed 2026-08-06 | $434.00K derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-03-31 | -$82.00K 10-Q · filed 2026-05-07 | $811.00K derived: sum of 2 quarters · filed 2026-05-07 | $517.00K derived: sum of 3 quarters · filed 2026-05-07 | $230.00K derived: sum of 4 quarters · filed 2026-05-07 | ||
| 2024-12-31 | $893.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $599.00K derived: sum of 2 quarters · filed 2026-03-12 | $312.00K derived: sum of 3 quarters · filed 2026-03-12 | $28.00K 10-K · filed 2026-03-12 | ||
| 2024-09-30 | -$294.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$581.00K derived: sum of 2 quarters · filed 2025-11-04 | -$865.00K 10-Q · filed 2025-11-04 | -$1.89M derived: sum of 4 quarters · filed 2026-03-12 | ||
| 2024-06-30 | -$287.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$571.00K 10-Q · filed 2025-08-07 | -$1.60M derived: sum of 3 quarters · filed 2026-03-12 | |||
| 2024-03-31 | -$284.00K 10-Q · filed 2025-05-08 | -$1.31M derived: sum of 2 quarters · filed 2026-03-12 | ||||
| 2023-12-31 | -$1.03M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$1.07M 10-K · filed 2026-03-12 | -$40.00K 10-K · filed 2024-03-19 | |||
| 2023-09-30 | -$40.00K 10-Q · filed 2023-11-07 | |||||
| 2022-12-31 | -$985.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-25 | -$973.00K 10-K · filed 2025-03-25 | -$107.00K 10-K · filed 2023-03-28 | |||
| 2022-09-30 | $12.00K 10-Q · filed 2023-11-07 | |||||
| 2021-12-31 | -$43.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | -$80.00K derived: sum of 2 quarters · filed 2024-03-19 | -$842.00K derived: sum of 3 quarters · filed 2024-03-19 | -$178.00K 10-K · filed 2024-03-19 | ||
| 2021-09-30 | -$37.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$799.00K derived: sum of 2 quarters · filed 2022-11-03 | -$135.00K 10-Q · filed 2022-11-03 | -$201.00K derived: sum of 4 quarters · filed 2023-03-28 | ||
| 2021-06-30 | -$762.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | -$98.00K 10-Q · filed 2022-08-08 | -$164.00K derived: sum of 3 quarters · filed 2023-03-28 | -$185.00K derived: sum of 4 quarters · filed 2023-03-28 | ||
| 2021-03-31 | $664.00K 10-Q · filed 2022-05-05 | $598.00K derived: sum of 2 quarters · filed 2023-03-28 | $577.00K derived: sum of 3 quarters · filed 2023-03-28 | |||
| 2020-12-31 | -$66.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | -$87.00K derived: sum of 2 quarters · filed 2023-03-28 | -$99.00K 10-K · filed 2023-03-28 | |||
| 2020-09-30 | -$21.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-01 | -$33.00K 10-Q · filed 2021-11-01 | ||||
| 2020-06-30 | -$12.00K 10-Q · filed 2021-08-02 | |||||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $0.00 derived: sum of 2 quarters · filed 2022-03-10 | -$1.00K derived: sum of 3 quarters · filed 2022-03-10 | $50.00K 10-K · filed 2022-03-10 | ||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | -$1.00K derived: sum of 2 quarters · filed 2020-10-29 | $50.00K 10-Q · filed 2020-10-29 | $50.00K derived: sum of 4 quarters · filed 2021-03-25 | ||
| 2019-06-30 | -$1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30 | $50.00K 10-Q · filed 2020-07-30 | $50.00K derived: sum of 3 quarters · filed 2021-03-25 | -$679.00K derived: sum of 4 quarters · filed 2021-03-25 | ||
| 2019-03-31 | $51.00K 10-Q · filed 2020-04-30 | $51.00K derived: sum of 2 quarters · filed 2021-03-25 | -$678.00K derived: sum of 3 quarters · filed 2021-03-25 | -$549.00K derived: sum of 4 quarters · filed 2021-03-25 | ||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | -$729.00K derived: sum of 2 quarters · filed 2021-03-25 | -$600.00K derived: sum of 3 quarters · filed 2021-03-25 | -$406.00K 10-K · filed 2021-03-25 | ||
| 2018-09-30 | -$729.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-29 | -$600.00K derived: sum of 2 quarters · filed 2019-10-29 | -$406.00K 10-Q · filed 2019-10-29 | |||
| 2018-06-30 | $129.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $323.00K 10-Q · filed 2019-08-01 | ||||
| 2018-03-31 | $194.00K 10-Q · filed 2019-05-09 | |||||
| 2017-09-30 | $189.00K 10-Q · filed 2018-11-01 | |||||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | $250.00K derived: sum of 2 quarters · filed 2019-03-07 | $269.00K derived: sum of 3 quarters · filed 2019-03-07 | $869.00K 10-K · filed 2019-03-07 | ||
| 2016-09-30 | $250.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $269.00K derived: sum of 2 quarters · filed 2017-11-02 | $869.00K 10-Q · filed 2017-11-02 | |||
| 2016-06-30 | $19.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $619.00K 10-Q · filed 2017-08-03 | ||||
| 2016-03-31 | $600.00K 10-Q · filed 2017-05-04 | -$600.00K 10-Q · filed 2016-05-05 | ||||
| 2015-09-30 | -$252.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | -$212.00K derived: sum of 2 quarters · filed 2016-11-03 | -$232.00K 10-Q · filed 2016-11-03 | |||
| 2015-06-30 | $40.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $20.00K 10-Q · filed 2016-08-04 | ||||
| 2015-03-31 | -$20.00K 10-Q · filed 2016-05-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Apnimed, Inc. (APMD) | United States | $0.899B |